In accordance with its reduced capacity for stimulating insulin release, exendin-asp3 failed to reduce apoptosis following glucolipotoxicity24 or endoplasmic reticulum stress25, both involved in T2D pathogenesis. This evidence concerns the gene INS and type 2 diabetes mellitus.